Berry Calls for Hearings on FDA, Vioxx
118917
WASHINGTON, DC - First District Congressman Marion Berry wrote to Congressional leaders today requesting the Energy and Commerce Committee hold a hearing on the Food &amp; Drug Administration&#39;s (FDA) handling of the Vioxx safety issue.
512837
Washington --- The Food and Drug Administration, accused in recent weeks of being cozy with the pharmaceutical industry, must open its practices to greater public scrutiny, says a top official of the agency&#39;s besieged Office of New Drugs.
86379
One of America&#39;s leading heart specialists is calling for less aggressive direct-to-consumer advertising of the arthritis pain drugs known as cox-2 inhibitors, in light of recent reports linking them to increased risk of heart attack and stroke.
496967
The House Energy and Commerce Committee is investigating how Vioxx was approved and then taken off the market. It has written to Lester Crawford, FDA, and Ray Gilmartin, CEO of Merck, requesting documents about Vioxx.
431979
Amid questions about whether the arthritis drug Vioxx was taken off the market soon enough, a key senator suggested Friday that an independent
284993
Doctors have been taking calls from anxious patients ever since a Senate hearing on Vioxx last week at which an FDA scientist expressed concerns about the safety of five other drugs on the market.
316239
Drugs in the same category as Merck & Co. Inc.'s withdrawn Vioxx painkiller will get close scrutiny to see if they also can cause heart attacks, U.S. regulators said on Thursday.
254339
Drug maker Merck & Co. Inc. on  Tuesday said its board appointed a committee to review the  company's actions prior to the voluntary withdrawal of its  painkiller Vioxx.
572114
A20-YEAR veteran of federal drug safety wars sent shock waves through the Food and Drug Administration and the pharmaceutical industry when he told a Senate hearing that regulators are &quot;incapable of protecting America against another Vioxx.
476114
WASHINGTON - The FDA scientist who studied the safety of the recalled painkiller Vioxx delivered a bombshell Thursday, naming five more drugs he believes could be dangerous.
611669
WASHINGTON/NEW YORK  - A U.S. Food and Drug  Administration reviewer who has accused the agency of being lax  in monitoring drug safety on Thursday said five medicines on  the market need closer scrutiny.
237814
Merck (MRK) officials on Wednesday called a press conference to reiterate that they did not believe until last month that Vioxx raised users&#39; risk of heart attacks or strokes.
453249
Law &amp; Order: Pharmaceutical Unit. Merck (nyse: MRK - news - people ) Chief Executive Raymond V. Gilmartin may testify in some of the many lawsuits filed over the Vioxx recall, a company lawyer said.
368795
The U.S. Food and Drug Administration on Friday asked an outside group to review the way the agency monitors safety risks of medicines after they hit the market, such as Merck & Co. Inc.'s withdrawn painkiller Vioxx.
455886
Drugs in the same category as Merck  & Co. Inc.'s withdrawn Vioxx painkiller will get close scrutiny  to see if they also can cause heart attacks, U.S. regulators  said on Thursday.
315893
Drug maker Merck &amp; Co. Inc. on Tuesday said its board appointed a committee to review the company&#39;s actions prior to the voluntary withdrawal of its painkiller Vioxx.
592608
Lawyers for customers suing Merck &amp; Co. want to question CEO Raymond Gilmartin about what he knew about the dangers of Vioxx before the company withdrew the drug from the market because of health hazards.